Signet Financial Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Signet Financial Management's WST Position: Q1 2022 in Review
Signet Financial Management sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 77 shares — an estimated $36K sold.
Signet Financial Management first reported a position in WST in Q4 2021 and held it in 1 quarter. The position peaked at $36K in Q4 2021. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.
- Signet Financial Management reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
- Signet Financial Management sold 77 West Pharmaceutical shares in Q1 2022, an estimated $36K.
- Signet Financial Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 1 quarter.
- Signet Financial Management's West Pharmaceutical position peaked at $36K in Q4 2021.
- 717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.
Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.